RT Journal Article
T1 Cell Therapy Clinical Trials for Stress Urinary Incontinence: Current Status and Perspectives.
A1 Aragón, Isabel María
A1 Imbroda, Bernardo Herrera
A1 Lara, María Fernanda
K1 Cell therapy
K1 Clinical trial
K1 Stem cells
K1 Stress Urinary incontinence
AB Stress urinary incontinence (SUI) affects 200 million people worldwide. Standard therapies often provide symptomatic relief, but without targeting the underlying etiology, and show tremendous patient-to-patient variability, limited success and complications associated with the procedures. We review in this article the latest clinical trials performed to treat SUI using cell-based therapies. These therapies, despite typically including only a small number of patients and short term evaluation of results, have proven to be feasible and safe. However, there is not yet a consensus for the best cell source to be used to treat SUI and not all patients may be suitable for these therapies. Therefore, more clinical trials should be promoted recruiting large number of patients and evaluating long term results.
YR 2018
FD 2018-01-01
LK http://hdl.handle.net/10668/12185
UL http://hdl.handle.net/10668/12185
LA en
DS RISalud
RD Apr 6, 2025